Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT2506 vs Simponi in Active Psoriatic Arthritis
CTR20210172Phase 3Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Feb 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of BAT2506 in psoriatic arthritis (PsA), sponsored by Bio-Thera Solutions, Ltd.. Started Feb 2021; status: completed.
02
Drugs
BAT2506
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on CTR20210172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210172.